{ "items": [ "\n\n
\n \n\n \n \n \n \n Arthritis\n \n \n \n \n Awards\n \n \n \n \n Botnar\n \n \n \n \n CSM\n \n \n \n \n Hand\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n9 January 2023
\n \n \n \nArani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.
\n \n\n \n \n\n \n\n \n \n \n \n Arthritis\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n5 January 2023
\n \n \n \nA study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.
\n \n\n \n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n4 January 2023
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n \n \n OACentre\n \n \n\n \n\n\n
\n \n\n \n22 December 2022
\n \n \n \nA new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n6 December 2022
\n \n \n \nA generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n5 December 2022
\n \n \n \nAn innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n2 December 2022
\n \n \n \nThe kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Botnar\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n1 December 2022
\n \n \n \nConrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n Kennedy\n \n \n\n \n\n\n
\n \n\n \n30 November 2022
\n \n \n \nAlex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation\u2019s sixth Emerging Leaders Prize.
\n \n\n \n \n\n \n\n \n \n \n \n Hand\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n15 November 2022
\n \n \n \nResearchers at the Kennedy Institute of Rheumatology and Oxford Population Health\u2019s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren\u2019s disease.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n CSM\n \n \n \n \n Hip\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n1 November 2022
\n \n \n \nWhat can patients learn from the experiences of people like them who\u2019ve already had a hip replacement? A new tool called \u2018Patients like me\u2019 helps answer some of the questions about pain, complications and how long the prosthesis might last.
\n \n\n \n \n\n \n\n \n \n \n \n Coronavirus COVID-19\n \n \n \n \n Main\n \n \n \n \n Statistics and epidemiology\n \n \n\n \n\n\n
\n \n\n \n28 October 2022
\n \n \n \nResearchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n25 October 2022
\n \n \n \nThe UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.
\n \n\n \n \n\n \n\n \n \n \n \n Main\n \n \n \n \n Orthopaedics and trauma\n \n \n\n \n\n\n
\n \n\n \n20 October 2022
\n \n \n \nA bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.
\n \n\n \n \n\n \n\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n19 October 2022
\n \n \n \nWelcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.
\n \n\n \n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Funding\n \n \n \n \n Kennedy\n \n \n \n \n Orthopaedics and trauma\n \n \n \n \n Trauma\n \n \n\n \n\n\n
\n \n\n \n17 October 2022
\n \n \n \nHealth and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
\n \n\n \n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n12 October 2022
\n \n \n \nOCTRU and the Experimental Medicine and Rheumatology trial group are delighted to announce that their latest study IMPROVE is now open and recruiting. The IMPROVE study is investigating if the immune response to COVID-19 vaccination can be improved in those with Chronic Lymphocytic Leukaemia (CLL) by pausing BTKi treatment for 3 weeks around the time of vaccination. The study is led by Dr Helen Parry at the University of Birmingham and funded by the NIHR and will recruit around 120 patients from 8 NHS Trusts in the UK. To coincide with the autumn COVID-19 vaccination programme all those involved in the study set have been working at great pace to reach this critical milestone and we look forward to supporting sites during the busy recruitment period.
\n \n\n \n \n\n \n\n \n \n \n \n OCTRU\n \n \n\n \n\n\n
\n \n\n \n12 October 2022
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Inflammation biology\n \n \n \n \n Kennedy\n \n \n \n \n Main\n \n \n\n \n\n\n
\n \n\n \n11 October 2022
\n \n \n \nThe Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
\n \n\n \n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n OCTRU\n \n \n \n \n Orthopaedics and trauma\n \n \n \n \n SITU\n \n \n\n \n\n\n
\n \n\n \n4 October 2022
\n \n \n \nCongratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.
\n \n\n \n \n